-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on ProMIS Neurosciences, Raises Price Target to $69

Benzinga·07/29/2026 14:15:40
Listen to the news
Guggenheim analyst Eddie Hickman maintains ProMIS Neurosciences (NASDAQ:PMN) with a Buy and raises the price target from $35 to $69.